MetLife Inc

MetLife Inc Stock Forecast & Price Prediction

Live MetLife Inc Stock (MET) Price
$83.25

16

Ratings

  • Buy 9
  • Hold 6
  • Sell 1
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$83.25

P/E Ratio

16.89

Volume Traded Today

$9.2M

Dividend

$0.545

52 Week High/low

86.95/59.24

MetLife Inc Market Cap

$57.64B

๐Ÿ›‘ Alert: These ten stocks could have higher potential than $MET ๐Ÿ›‘

Before you buy MET you'll want to see this list of ten stocks that have huge potential. Want to see if MET made the cut? Enter your email below

MET Summary

The MetLife Inc (MET) share price is expected to increase by 9.25% over the next year. This is based on calculating the average 12-month share price estimate provided by 16 stock analysts who have covered MET. Price targets range from $81 at the low end to $98 at the high end. The current analyst consensus for MET is a buy. Please note analyst price targets are not guaranteed and could be missed completely.

MET Analyst Ratings

MetLife Inc has a total of 16 Wall St Analyst ratings. There are 9 buy ratings, 6 ratings, and 1 sell ratings. Since most analysts have a buy consensus rating, the expectation is that MetLife Inc will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.

MET stock forecast by analyst

These are the latest 20 analyst ratings of MET.

Analyst/Firm

Rating

Price Target

Change

Date

Elyse Greenspan
Wells Fargo

Overweight

$93

Maintains

Nov 5, 2024
Alex Scott
Barclays

Overweight

$90

Maintains

Oct 31, 2024
Elyse Greenspan
Wells Fargo

Overweight

$92

Maintains

Oct 10, 2024
Daniel Bergman
TD Cowen

Buy

$97

Initiates

Oct 9, 2024
John Barnidge
Piper Sandler

Overweight

$92

Maintains

Oct 2, 2024
Suneet Kamath
Jefferies

Buy

$95

Maintains

Sep 27, 2024
Alex Scott
Barclays

Overweight

$91

Initiates

Sep 4, 2024
Nigel Dally
Morgan Stanley

Overweight

$85

Maintains

Aug 19, 2024
Elyse Greenspan
Wells Fargo

Overweight

$86

Maintains

Aug 12, 2024
Joshua Shanker
B of A Securities

Buy

$96

Maintains

Aug 1, 2024
Michael Ward
Citigroup

Buy

$89

Maintains

Jul 23, 2024
Suneet Kamath
Jefferies

Buy

$86

Maintains

Jul 18, 2024
Nigel Dally
Morgan Stanley

Overweight

$83

Maintains

Jul 10, 2024
Ryan Krueger
Keefe, Bruyette & Woods

Outperform

$85

Maintains

Jul 8, 2024
Jimmy Bhullar
JP Morgan

Overweight

$86

Maintains

Jul 2, 2024
Suneet Kamath
Jefferies

Buy

$83

Maintains

Jun 28, 2024
Kevin Heal
Argus Research

Buy

$80

Maintains

May 22, 2024
Elyse Greenspan
Wells Fargo

Overweight

$85

Maintains

May 10, 2024
Ryan Krueger
Keefe, Bruyette & Woods

Outperform

$86

Maintains

May 7, 2024
John Barnidge
Piper Sandler

Overweight

$82

Maintains

May 6, 2024

MET Company Information

What They Do: Provides global insurance and financial services.

Business Model: MetLife generates revenue through a diverse range of insurance products, annuities, and employee benefits. The company operates in multiple segments, including retirement solutions, group benefits, and international markets, allowing it to cater to various customer needs while also offering capital market investment products.

Other Information: Incorporated in 1999 and headquartered in New York, MetLife has a strong presence worldwide, providing life, health, and retirement solutions. The company also engages in innovative financial products like pension risk transfers and longevity reinsurance, positioning itself as a comprehensive financial services provider.
MET
MetLife Inc (MET)

When did it IPO

2000

Staff Count

45,000

Country

United States

Sector/Industry

Financial Services/Insurance - Life

CEO

Mr. Michel Abbas Khalaf

Market Cap

$57.64B

MetLife Inc (MET) Financial Data

In 2023, MET generated $66.41B in revenue, which was a decrease of -2.09% from the previous year. This can be seen as a signal that MET's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

$66.77B

Revenue From 2021

$63.65B

-4.67 %
From Previous Year

Revenue From 2022

$67.82B

6.55 %
From Previous Year

Revenue From 2023

$66.41B

-2.09 %
From Previous Year
  • Revenue TTM $71.34B
  • Operating Margin TTM 15.1%
  • Gross profit TTM $0
  • Return on assets TTM 0.6%
  • Return on equity TTM 13.3%
  • Profit Margin 5.3%
  • Book Value Per Share 44.53%
  • Market capitalisation $57.64B
  • Revenue for 2021 $63.65B
  • Revenue for 2022 $67.82B
  • Revenue for 2023 $66.41B
  • EPS this year (TTM) $4.93

MetLife Inc (MET) Latest News

News Image

Wed, 30 Oct 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - MetLife reported Q3 2024 net income of $1.3 billion ($1.81/share), up from $422 million ($0.56/share) in Q3 2023. Adjusted earnings were $1.4 billion ($1.95/share). Book value rose 33% to $39.02/share.

Why It Matters - MetLife's significant net income increase and 33% rise in book value indicate strong financial health, potentially boosting investor confidence and stock value.

News Image

Wed, 30 Oct 2024

Sentiment - NEGATIVE

Source - Zacks Investment Research

Summary - MetLife (MET) reported Q3 earnings of $1.93 per share, missing the Zacks estimate of $2.16 and down from $1.97 per share year-over-year.

Why It Matters - MetLife's earnings miss indicates potential operational challenges and may signal future profitability concerns, impacting stock performance and investor confidence.

News Image

Thu, 31 Oct 2024

Sentiment - NEUTRAL

Source - Seeking Alpha

Summary - MetLife, Inc. will host its Q3 2024 earnings conference call on October 31, 2024, at 9:00 AM ET, featuring key executives and analysts from major financial firms.

Why It Matters - MetLife's Q3 2024 earnings call reveals insights into financial performance, strategies, and market conditions, directly influencing stock prices and investment decisions.

News Image

Wed, 30 Oct 2024

Sentiment - NEUTRAL

Source - Business Wire

Summary - MetLife, Inc. (NYSE: MET) announced a third quarter 2024 financial update from CFO John McCallion, available on their website.

Why It Matters - MetLife's CFO's financial update may signal insights into the company's performance and strategy, impacting investor sentiment and stock valuation ahead of Q3 results.

News Image

Wed, 30 Oct 2024

Sentiment - POSITIVE

Source - Zacks Investment Research

Summary - MetLife (MET) reported its quarterly performance for September 2024; investors should compare key metrics against Wall Street estimates and year-ago figures for insight.

Why It Matters - MetLife's quarterly performance compared to estimates and prior year results can indicate growth trends, profitability, and market positioning, influencing investor sentiment and stock valuation.

News Image

Thu, 31 Oct 2024

Sentiment - NEGATIVE

Source - Zacks Investment Research

Summary - MET's third-quarter earnings declined due to increased expenses and a reduced recurring interest margin in its Risk and Insurance Services (RIS) segment.

Why It Matters - Higher expenses and a lower recurring interest margin in RIS could indicate reduced profitability for MET, potentially impacting share value and investor confidence.

...

MET Frequently asked questions

The highest forecasted price for MET is $98 from at .

The lowest forecasted price for MET is $81 from Michael Ward from Citigroup

The MET analyst ratings consensus are 9 buy ratings, 6 hold ratings, and 1 sell ratings.